Company facts
- Headquarters
- San Diego, California
- Most recent report
- 10-Q, filed Nov 9, 2026
- Incorporated
- Delaware
- Filings on record
- 557 filings
- On EDGAR
- CIK 1326110
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 46
News 8 of 102
- 8-K Quarterly results Nov 9, 2026
- 8-K Current report on a material event Nov 9, 2026
- 8-K Current report on a material event Oct 14, 2026
- 8-K Quarterly results Aug 4, 2026
- 8-K Current report on a material event Jul 30, 2026
- 8-K Shareholder vote results Jun 10, 2026
- 8-K Significant contract May 18, 2026
- 8-K Quarterly results May 7, 2026
Prospectuses and Registrations 8 of 41
- 424B5 Prospectus supplement for an offering Dec 29, 2025
- 424B5 Prospectus supplement for an offering Jul 28, 2025
- S-8 Registration statement for an employee plan Jun 23, 2025
- 424B5 Prospectus supplement for an offering Apr 8, 2025
- 424B5 Prospectus supplement for an offering Dec 12, 2024
- 424B5 Prospectus supplement for an offering Dec 10, 2024
- S-8 Registration statement for an employee plan Jun 20, 2024
- S-3ASR Automatic shelf registration Apr 17, 2024
Proxies 8 of 17
- DEFA14A Extra proxy material Apr 30, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2026
- DEFA14A Extra proxy material Apr 30, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2025
- DEFA14A Extra proxy material Apr 29, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
- DEFA14A Extra proxy material Apr 28, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2023
Ownership 8 of 281
- 4 Insider reported a trade Oct 6, 2026
- 4 Insider reported a trade Oct 6, 2026
- 144 Notice of a proposed sale of restricted stock Oct 5, 2026
- 144 Notice of a proposed sale of restricted stock Oct 2, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Aug 6, 2026
- 4 Insider reported a trade Jul 6, 2026
- 4 Insider reported a trade Jul 6, 2026
- 144 Notice of a proposed sale of restricted stock Jul 2, 2026
Other 8 of 70
- ARS Annual report sent to shareholders Apr 30, 2026
- DEF 14C Oct 20, 2025
- PRE 14C Oct 8, 2025
- ARS Annual report sent to shareholders Apr 30, 2025
- EFFECT Notice that a registration became effective May 2, 2024
- CORRESP Reply to SEC staff Apr 30, 2024
- ARS Annual report sent to shareholders Apr 29, 2024
- UPLOAD Comment letter from SEC staff Apr 3, 2024
Everything here comes from ImmunityBio, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.